Obesity drug dropped as 'too risky'

GPs warn treatment options should not be limited where a benefit is shown.

Dr Haslam: 'benefits lost'
Dr Haslam: 'benefits lost'

GPs have expressed disappointment at the suspension of the weight-loss drug rimonabant.

Dr Ian Campbell, a GP in Nottingham and medical director of the charity Weight Concern, said prescribers are aware of the drug's adverse effects on anxiety and depression and monitored patients closely.

'It is disappointing for those patients for whom the drug is working,' he said.

Around 20,000 patients in the UK have been treated with rimonabant, marketed as Acomplia, but last week the European Medicines Agency (EMEA) decided that its benefits no longer outweigh its risks.

Prescribers should not issue any new prescriptions for the drug, the EMEA said.

Patients do not need to stop treatment immediately, but those who wish to stop can do so at any time, the EMEA advised.

Dr David Haslam, a GP in Hertfordshire and clinical director of the National Obesity Forum, said the move was 'a great shame'.

'I have patients whose diabetes is well controlled who have benefited from rimonabant and that benefit will end when their treatment ends.'

The drug's manufacturer Sanofi-Aventis said it was complying with the EMEA's recommendation and would provide additional evidence for re-evaluation of the drug's benefit-risk profile in patients with diabetes and cardiovascular disease.

The EMEA said its assessment showed an increased risk of psychiatric disorders in patients taking rimonabant. In addition, the agency said that the drug's effectiveness in clinical practice had been found to be more limited than was expected.

Sir Michael Rawlins, chairman of NICE, told GP that the institute had withdrawn its June guidance, which recommended the drug for third-line use after orlistat and sibutramine.


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

£20 notes spread out

VAT trap for PCNs could strip millions of pounds from general practice

Tens of millions of pounds could be stripped from general practice because work carried...

Talking General Practice logo

Podcast: Is the BMA representing GPs effectively, why GPs face a pension tax hit, and views on the workload crisis

In our regular news review the team discusses representation of GPs, a new survey...

Man sleeping

NICE guidance on insomnia backs app to replace sleeping pills

Hundreds of thousands of people with insomnia could be offered treatment via a mobile...

Health worker prepares a dose of COVID-19 vaccine

JCVI backs autumn COVID-19 booster campaign for high-risk adults and NHS staff

Frontline health and social care staff and adults at increased risk of severe illness...

GP consultation

Government accused of 'misleading' claims on general practice workforce

GP leaders have accused the government of making misleading claims about the general...

Consulting room door

LMC calls for enhanced access to be scrapped after abuse forces practice to close reception

A Midlands LMC has backed a practice forced to close its reception desk after abuse...